NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

Thats great as PFS is a statistical objective but once again per normal some posters just continue to be confused and confounded. The good news is that the OS data prevailed, and the doctors, scientist and professionals agree that the OS was in fact impressive to say the least. Time to move on per
the FDA guidance, Clinical trial endpoints, approval of Cancer drugs and Biologics

With respect to NWBO and DCVAx=L
ALL of these endpoints are accepted for FDA approval consideration.
- Overall Survival, OS results surpass PFS predictions
- Disease-Free Survival (and Event-Free Survival), Survival better than current SOC
- Objective Response Rate, at least 2.5X that of present SOC chemo poison
- Complete Response, Same as above and potential longer timeframes, great OS.
- Time to Progression and Progression-Free Survival, again at least 2.5X that of present SOC chemo poison.
- Time to Treatment Failure, at least 2.5X beyond that of present SOC

Based on the real facts about DCVax-L, this is looking better than the current SOC chemo poison, IMPO.
Looking forward to more good news as NWBO moves forward